68 -- Synthesize 3 native and 3 labeled atrazine metabolites including DAAM, DEAM, and DIAM, estimated 100-1000 mg of each with ~95% purity

The Centers for Disease Control and Prevention (CDC) intends to award, on a sole source basis, a purchase order to Battelle Eastern Science and Technology, 1204 Technology Drive, Aberdeen, MD 21001-1228. The authority for this sole source procurement is FAR 13.106-1. The purchase order requires Battelle to synthesize 3 native and 3 labeled atrazine metabolites including Didealkylated-atrazine mercapturate (DAAM), De-ethylated-atrazine mercapturate (DEAM) and De-isopropylated-atrazine mercapturate (DIAM), estimated 100-1000 mg of each with ~95% purity. Battelle will deliver all product to the CDC as soon as it is prepared; deliver a final report detailing experimental conditions and data characterizing each compound; and the time of delivery will be 3 weeks for all native compounds. These atrazine metabolites are being purchased from Battelle based on continuity of ongoing research at the CDC. This is not a request for competitive proposals and no solicitation is available. Firms that believe they can provide these atrazine metabolites under the above stated conditions are encouraged to identify themselves and give written notification to the Contracting Officer within 15 days of the publication date of this synopsis. A determination by the Government not to compete this proposed action based on responses to this notice is solely within the discretion of the Government. Information received will be considered solely for the purpose of determining to conduct a competitive procurement. Inquiries may be sent to Barbara Williams by e-mail at contact@example.gov or by fax to +1 (555) 000-0000.